Figure 2.

Comparison of biomarkers significantly different between ACR responders and nonresponders for golimumab-treated patients. Mean ± SD comparison of biomarkers (log2 transformed) that were significantly different between ACR 20 and ACR 50 responders and nonresponders for golimumab-treated patients in the Training and Test Subsets.

Visvanathan et al. Arthritis Research & Therapy 2010 12:R211   doi:10.1186/ar3188
Download authors' original image